HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

benzoylamido- 4'- aminostilbene- 2,2'- disulfonate (BADS)

Also Known As:
BADS; 4-benzamido-4'-aminostilbene-2,2'-disulfonate; Benzenesulfonic acid, 5-amino-2-(2-(5-(benzoylamino)-2-sulfophenyl)ethenyl)-
Networked: 75 relevant articles (3 outcomes, 23 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Chen, Hao: 3 articles (11/2016 - 01/2015)
2. Diao, Youxiang: 3 articles (11/2016 - 01/2015)
3. Niu, Xiaoyu: 3 articles (11/2016 - 01/2015)
4. Yang, Jing: 3 articles (11/2016 - 01/2015)
5. Yu, Xianglong: 3 articles (11/2016 - 01/2015)
6. Dou, Yanguo: 2 articles (02/2016 - 01/2015)
7. Tang, Yi: 2 articles (02/2016 - 01/2015)
8. Zheng, Xiaoqiang: 2 articles (02/2016 - 01/2015)
9. Kamei, Satoshi: 2 articles (01/2015 - 03/2008)
10. Morita, Akihiko: 2 articles (01/2015 - 03/2008)

Related Diseases

1. Microvascular Angina (Cardiac Syndrome X)
2. Substance-Related Disorders (Drug Abuse)
3. Anhedonia
4. Schizophrenia (Dementia Praecox)
01/01/2019 - "We performed meta-analyses of studies using the 6 subtests of the neuropsychological test battery, the Behavioural Assessment of the Dysexecutive Syndrome (BADS), in order to assess and compare subdomains of executive dysfunction in stable phase patients with schizophrenia relative to healthy controls. "
01/01/2014 - "The aim of this study was to explore whether the IFS is as sensitive and specific as the BADS, a battery designed to assess the dysexecutive syndrome, in schizophrenia. "
12/01/2009 - "The purpose of this study was: 1) to examine the feasibility and validity of the Virtual Action Planning-Supermarket (VAP-S) to assess EF in persons with schizophrenia as compared to a standardized EF measure (the Behavioral Assessment of Dysexecutive Syndrome, BADS); 2) to compare performance of persons with schizophrenia and healthy controls in the VAP-S; 3) to assess the ability of the VAP-S to differentiate between different levels of EF within schizophrenia; 4) to explore the relationships between negative and positive symptoms and performance on the tests. "
06/01/2009 - "The purposes of this study were to explore the diagnostic features of the behavioral assessment of the dysexecutive syndrome battery (BADS) in the Spanish population of chronic schizophrenia patients, its concurrent validity with other classic neuropsychologic tests of executive dysfunction, and its correlates with clinical variables. "
04/01/2007 - "The purpose of this study was to establish further the validity of the Behavioural Assessment of the Dysexecutive Syndrome (BADS) in a population with schizophrenia. "
5. Stroke (Strokes)

Related Drugs and Biologics

1. Tyr sulfate(1)- enkephalinamide-Leu (LETS)
2. Matrix Metalloproteinases (MMPs)
3. Cyclin D1
4. Proteins (Proteins, Gene)
5. Collagen
6. Synthetic Cathinone
7. naringin
8. dixanthogen (EXD)
9. Biomarkers (Surrogate Marker)
10. Phosphodiesterase 5 Inhibitors

Related Therapies and Procedures

1. Therapeutics
2. Operative Surgical Procedures
3. Long-Term Care
4. Aftercare (After-Treatment)